- Long|term health impacts of hematopoietic stem cell transplantation ...🔍
- Stem cell transplant prolongs survival🔍
- Prolonged survival of transplanted stem cells after ischaemic injury ...🔍
- Improved progression|free survival in patients with multiple ...🔍
- Long|Term Survival and Late Deaths After Allogeneic Hematopoietic ...🔍
- Long|Term Survival for Myeloma after Autologous Stem Cell ...🔍
- Long|term outcomes after autologous stem cell transplantation for ...🔍
- Low Nonrelapse Mortality and Prolonged Long|Term Survival after ...🔍
Stem cell transplant prolongs survival
Long-term health impacts of hematopoietic stem cell transplantation ...
HSCT patients who have survived for at least 5 years post-transplantation are at a fourfold to ninefold increased risk of late mortality for as long as 30 years ...
Stem cell transplant prolongs survival, delays cancer progression...
A standard autologous hematopoietic stem cell transplant (AHSCT) safely and effectively prolongs survival and delays cancer progression in ...
Prolonged survival of transplanted stem cells after ischaemic injury ...
Stem-cell-based therapies hold considerable promise for regenerative medicine. However, acute donor-cell death within several weeks after ...
Improved progression-free survival in patients with multiple ...
However, patients were just as likely to be alive more than six years after treatment regardless of whether they underwent an immediate stem ...
Long-Term Survival and Late Deaths After Allogeneic Hematopoietic ...
However, both studies indicate that, as patients survive longer post transplantation, the risks of mortality continue to decrease over time and may eventually ...
Long-Term Survival for Myeloma after Autologous Stem Cell ...
Majority of long-term survivors were relapse-free at 24 months from transplant (76%) compared to only 32% in the short-term survival group. On multivariable ...
Long-term outcomes after autologous stem cell transplantation for ...
A Surveillance, Epidemiology, and End Results (SEER)–based analysis of long-term survival in MM patients reported steady improvements over time, ...
Low Nonrelapse Mortality and Prolonged Long-Term Survival after ...
... cell lymphoma (DLBCL) have a very poor prognosis. However, they may achieve long-term survival by undergoing allogeneic stem cell transplantation (SCT). The ...
Allogeneic stem cell transplantation can prolong the survival of ...
Allogeneic hematopoietic stem cell transplantation for adult acute myeloid leukemia patients with nucleoporin 98 (NUP98) gene rearrangements: a real-world ...
Double Autologous Stem Cell Transplantation Significantly Prolongs ...
Overall survival (OS) from R1 was significantly prolonged with ASCT-2 as compared with ASCT-1 (3-year rate: 89% vs 82%; HR=0.52; CI=0.31-0.86; P=0.011) (Fig. 1c) ...
Second ASCT Extends Survival in Relapsed Multiple Myeloma
A combination of maintenance therapy and second autologous stem cell transplant (ASCT) for patients who have relapsed multiple myeloma (MM) extended the ...
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
In conclusion, this study suggests that lenalidomide maintenance therapy until disease progression is feasible for prolonged administration. The ...
Early consolidation by myeloablative radiochemotherapy followed ...
Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression- ...
Emapalumab Extends 'Intervention-Free' Survival for Children with ...
Reduced-intensity conditioning hematopoietic stem cell transplantation (RIC-HSCT)—pioneered by the Bone Marrow Transplantation Program here—uses ...
Favorable Overall Survival with Fully Myeloablative Allogeneic Stem ...
Allogeneic stem cell transplantation (Allo-SCT) remains an option for patients with follicular lymphoma (FL). We performed a retrospective analysis to ...
Consolidation Therapy With Low-Dose Thalidomide and ...
... Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure ... prolongs survival when used ...
Myeloma Patients, after HSCT, Improve Survival with Revlimid
Longer duration of maintenance therapy with Revlimid (lenalidomide) after autologous hematopoietic stem cell transplantation (HSCT) prolongs survival for ...
Longitudinal Survival Outcomes in Allogeneic Stem Cell ... - MDPI
Stem cell transplantation from a donor can be a potential cure for several blood cancers. We have maintained the characteristics and outcomes of patients ...
Prolonged survival of transplanted stem cells after ischaemic injury ...
Co-transplantation of stem cells with pro-survival factors can improve cell engraftment, but this strategy has been hampered by the typically short half-lives ...
Stem Cell Transplant for Multiple Myeloma - Massive Bio
Long-term survival is achievable, especially when the immune system remains strong and infections are minimized. The patient's quality of life ...